Literature DB >> 9341898

Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

K Ashida1, Y Kishimoto, K Nakamoto, K Wada, G Shiota, Y Hirooka, Y Kamisaki, T Itoh, H Kawasaki.   

Abstract

Carcinogenesis is a multistep process. Most hepatocellular carcinoma (HCC) is preceded by liver cirrhosis, but the genetic changes involved in cirrhosis are not known well. The present study was conducted to evaluate aberration of the retinoblastoma (RB) gene in HCC and adjacent non-tumorous liver using 22 patients with chronic liver damage accompanying HCC. The specimens obtained by microdissection from paraffin-embedded tissues were analyzed using an assay based on the polymerase chain reaction for highly polymorphic nucleotide sequences of microsatellites in the RB gene. Out of 22 cases, 15 showed constitutional heterozygosity for the microsatellite markers. In 11 (73.3%) of these 15 informative cases, the primary HCC foci showed loss of heterozygosity (LOH). In 8 of these 11 doubly informative (informative and LOH-positive in primary HCC) cases, LOH was found in 20 (64.5%) of 31 microdissected non-tumorous foci. All of the non-tumorous foci showing RB loss were cirrhotic lesions but there were no foci of chronic hepatitis. The remaining 4 cases without LOH in HCC foci showed no LOH in non-tumorous lesions. In our study, LOH of the RB gene was frequently observed in liver cirrhosis surrounding tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341898     DOI: 10.1007/bf01192203

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  57 in total

1.  Altered expression of the retinoblastoma gene product in human sarcomas.

Authors:  W G Cance; M F Brennan; M E Dudas; C M Huang; C Cordon-Cardo
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

2.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

3.  The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Authors:  A Borg; Q X Zhang; P Alm; H Olsson; G Sellberg
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

4.  Loss of somatic heterozygosity in hepatocellular carcinoma.

Authors:  G J Walker; N K Hayward; S Falvey; W G Cooksley
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

5.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

7.  p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

Authors:  V Sundaresan; P Ganly; P Hasleton; R Rudd; G Sinha; N M Bleehen; P Rabbitts
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

8.  Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; T Sadamoto; G Isowa; K Honda; Y Yamaoka; M Ikenaga; H Imura; K Ishizaki
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

9.  Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

Authors:  H J Xu; S X Hu; P T Cagle; G E Moore; W F Benedict
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

10.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.

Authors:  Y Kishimoto; K Sugio; J Y Hung; A K Virmani; D D McIntire; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

View more
  6 in total

1.  Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.

Authors:  S J Moghaddam; E N Haghighi; S Samiee; N Shahid; A R Keramati; S Dadgar; M R Zali
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

2.  Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors.

Authors:  Li Peng; Christopher N Mayhew; Michael Schnekenburger; Erik S Knudsen; Alvaro Puga
Journal:  Toxicology       Date:  2008-01-16       Impact factor: 4.221

3.  Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.

Authors:  Wei-Guo Deng; Yan Fu; Yu-Lin Li; Toshihiro Sugiyama
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

4.  Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators.

Authors:  T Schlott; J G Scharf; C Gorzel; P Middel; H Spring
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

5.  Dietary fat/cholesterol-sensitive PKCβ-RB signaling: Potential role in NASH/HCC axis.

Authors:  Wei Huang; Devina Mehta; Said Sif; Lindsey N Kent; Samson T Jacob; Kalpana Ghoshal; Kamal D Mehta
Journal:  Oncotarget       Date:  2017-05-15

6.  MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness.

Authors:  Seongki Min; Young-Kyoung Lee; Jiwon Hong; Tae Jun Park; Hyun Goo Woo; So Mee Kwon; Gyesoon Yoon
Journal:  Cell Death Dis       Date:  2021-11-12       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.